bioavailability
506 results
1 - 100- bioavailability
- yohimbine
- NIFEdipine
- mitoMYcin
- dabigatran
- edaravone
- azaCITIDine
- sipuleucel
- treprostinil (parenteral)
- nivolumab
- natalizumab
- tiludronate
- trastuzumab
- aMILoride
- ipilimumab
- drotrecogin
- laronidase
- availability
- idursulfase
- velaglucerase alfa
- elotuzumab
- prodrug
- dronedarone
- panitumumab
- alglucosidase
- cetuximab
- palifermin
- carrier prodrug, carrier-linked prodrug
- raxibacumab
- atezolizumab
- durvalumab
- olaratumab
- alemtuzumab
- fennel
- taliglucerase alfa
- dinutuximab
- obiltoxaximab
- anifrolumab
- cidofovir
- agalsidase beta
- obinutuzumab
- pembrolizumab
- sebelipase alfa
- calaspargase
- mogamulizumab
- naxitamab
- bevacizumab
- etoposide
- leucovorin calcium
- decitabine
- eculizumab
- pegloticase
- pertuzumab
- bezlotoxumab
- necitumumab
- ocrelizumab
- ibalizumab
- cytomegalovirus immune globulin
- lymphocyte immune globulin
- rasburicase
- spironolactone
- gonadorelin acetate
- ranibizumab
- C1-esterase inhibitor
- belatacept
- ziv-aflibercept
- peramivir
- ramucirumab
- vedolizumab
- ferric pyrophosphate citrate
- avelumab
- eteplirsen
- cemiplimab
- ravulizumab
- basiliximab
- denileukin diftitox
- imiglucerase
- clofarabine
- glucarpidase
- anthrax immune globulin
- amifostine
- dexrazoxane
- DOBUTamine
- DAPTOmycin
- ISOSORBIDE
- tenecteplase
- abatacept
- aliskiren
- ambrisentan
- tositumomab (I 131 tositumomab)
- blinatumomab
- C1-esterase inhibitor, recombinant
- siltuximab
- reslizumab
- ePHEDrine
- isatuximab
- golodirsen
- esmolol
- plasma protein fraction
- trace metal combination additive